Sullivan Christopher Ryan bought AVTX
August 17, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan bought 37,945 shares of Avalo Therapeutics, Inc. at $9.88 per share, a transaction worth $374.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
37,945
Price
$9.88
Total value
$374.9K
InsiderSullivan Christopher Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 17, 2026
Filing dateAugust 19, 2026
Shares owned after78,718
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.